Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid.
Saved in:
| Title: | Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid. |
|---|---|
| Authors: | Ratnarajah K; Division of Dermatology, McGill University Health Center, Montreal, Quebec, Canada., Arès S; Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada., Kechichian E; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada., Fernandes CL; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada. |
| Source: | JAAD case reports [JAAD Case Rep] 2025 Aug 19; Vol. 65, pp. 201-205. Date of Electronic Publication: 2025 Aug 19 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101665210 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5126 (Print) Linking ISSN: 23525126 NLM ISO Abbreviation: JAAD Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41143232 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ratnarajah+K%22">Ratnarajah K</searchLink>; Division of Dermatology, McGill University Health Center, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Arès+S%22">Arès S</searchLink>; Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Kechichian+E%22">Kechichian E</searchLink>; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Fernandes+CL%22">Fernandes CL</searchLink>; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101665210%22">JAAD case reports</searchLink> [JAAD Case Rep] 2025 Aug 19; Vol. 65, pp. 201-205. <i>Date of Electronic Publication: </i>2025 Aug 19 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101665210 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2352-5126 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223525126%22">23525126 </searchLink><i>NLM ISO Abbreviation: </i>JAAD Case Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41143232 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jdcr.2025.08.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 201 Titles: – TitleFull: Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ratnarajah K – PersonEntity: Name: NameFull: Arès S – PersonEntity: Name: NameFull: Kechichian E – PersonEntity: Name: NameFull: Fernandes CL IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 08 Text: 2025 Aug 19 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2352-5126 Numbering: – Type: volume Value: 65 Titles: – TitleFull: JAAD case reports Type: main |
| ResultId | 1 |